학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 124건 | 목록 1~20
Academic Journal
Sesques P; Department of Hematology, Hospices Civils de Lyon, Hopital Lyon-Sud, Claude Bernard Lyon 1 University, Lyon, France.; Manson G; Department of Hematology, Centre Hospitalier Universitaire de Rennes, Université de Rennes, INSERM U1236, Rennes, France.; Dubois S; Department of Hematology, Centre Henri Becquerel, Rouen, France; Université Rouen Normandie, INSERM U1245, Rouen, France.; Gros FX; Department of Hematology-Transplantation, CHU de Bordeaux, Pessac, France.; Brisou G; Department of Onco-Hématology, Institut Paoli-Calmettes, Marseille, France.; Sarkozy C; Department of Hematology, Institut Curie, Saint-Cloud, France.; Bernard S; Department of Hematology, Centre Hospitalier de la Cote Basque, Bayonne, France.; Bourbon E; Department of Hematology, Hospices Civils de Lyon, Hopital Lyon-Sud, Claude Bernard Lyon 1 University, Lyon, France.; Fornecker LM; Department of Hematology, Institut Cancérologie Strasbourg Europe, Strasbourg, France.; Durot E; Department of Hematology, CHU de Reims, Reims, France.; Martin L; Department of Pathology, CHU de Dijon, Dijon, France.; Chassagne-Clément C; Department of Pathology, Centre Régional de Lutte Contre le Cancer Centre Léon Bérard, Lyon, France.; Llamas Gutierrez F; Department of Pathology, CHU de Rennes, Rennes, France.; Syrykh C; Department of Pathology, CHU Toulouse, Toulouse, France.; Delfau-Larue MH; Laboratoire d'Hématologie, AP-HP, Hôpital Henri-Mondor, Créteil, France.; Kanoun S; Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse, Toulouse, France.; Vercellino L; Department of Nuclear Medicine, AP-HP, Saint-Louis, Paris, France; Université Paris Cité, Paris, France.; Bodet-Milin C; Department of Nuclear Medicine, CHU de Nantes, Nantes, France.; Bahri H; Department of Nuclear Medicine, Centre Régional de Lutte Contre le Cancer Centre Léon Bérard, Lyon, France.; Zhang Yin J; Department of Nuclear Medicine, Clinique Sud Luxembourg, Vivalia, Belgique, Arlon, France.; Dony A; Department of Hematology, CH Métropole Savoie, Chambéry, France.; Lebras L; Department of Hematology, Centre Régional de Lutte Contre le Cancer Centre Léon Bérard, Lyon, France.; Ochmann M; Department of Hematology, CHU d'Orléans, Orléans, France.; Baron M; Department of Hematology, AP-HP, Pitié Salpêtrière, Paris, France.; Monjanel H; Department of Hematology, CH Henri Mondor, Aurillac, France.; Le Calloch R; Department of Hematology, CH Quimper, Quimper, France.; Claves F; Department of Hematology, CHU Grenoble, Grenoble, France.; Kirova Y; Department of Radiation Oncology, Institut Curie, Paris, France.; Gisselbrecht C; Department of Hematology, IUH - Institut Universitaire d'Hématologie Saint Louis, Paris, France.; Guidez S; Department of Hematology, CHU de Poitiers, Poitiers, France.; Bossard JB; Department of Hematology, CH Lens, Lens, France.; Di Blasi R; Department of Hematology, AP-HP, Saint Louis, Paris, France.; Delette C; Department of Hematology, CHU Amiens, Amiens, France.; Fouillet L; Department of Hematology, CHU Saint Etienne, Saint Etienne, France.; Rhomdani M; Department of Hematology, Centre Hospitalier d'Argenteuil Victor Dupouy, Argenteuil, France.; Belhadj M; Department of Hematology, CHU Saint Pierre, France.; Crochet G; Department of Hematology, CHU UCL Namur, Belgique, Namur, France.; Amorim S; Department of Hematology and cellular therapy, Hôpital Saint Vincent de Paul, Lille, France.; Safa F; Department of Hematology, CH du Mans, Le Mans, France.; Drieu La Rochelle L; Department of Hematology, CHU Tours, Tours, France.; Abraham J; Department of Hematology, CHU Limoges, Limoges, France.; Thieblemont C; Department of Nuclear Medicine, AP-HP, Saint-Louis, Paris, France; Université Paris Cité, Paris, France.; Jardin F; Department of Hematology, Centre Hospitalier Universitaire de Rennes, Université de Rennes, INSERM U1236, Rennes, France.; Noel R; Department of Onco-Hématology, Institut Paoli-Calmettes, Marseille, France.; Bailly S; Department of Hematology, CHU Clermont-Ferrand, Clemront-Ferrand, France.; Renaud L; Department of Hematology, Gustave Roussy, Villejuif, France.; Guillermin Y; Department of Hematology, Centre Régional de Lutte Contre le Cancer Centre Léon Bérard, Lyon, France.; Delapierre B; Department of Hematology, CHU de Caen, Caen, France.; Choquet S; Department of Hematology, AP-HP, Pitié Salpêtrière, Paris, France.; Roulin L; Department of Hematology, AP-HP, Centre Henri Mondor, Créteil, France.; Lamure S; Department of Hematology, Centre Régional de Lutte Contre le Cancer Centre Léon Bérard, Lyon, France; Service d'onco-hématologie, Hôpitaux Nord Ouest, Villefranche sur Saone, France.; Galicier L; Department of Hematology, AP-HM, La Timone, Marseille, France.; Al Tabaa Y; Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier, France.; Soussain C; Department of Hematology, Institut Curie, Saint-Cloud, France.; Guièze R; Department of Hematology, CHU Clermont-Ferrand, Clemront-Ferrand, France.; Houot R; Department of Hematology, Centre Hospitalier Universitaire de Rennes, Université de Rennes, INSERM U1236, Rennes, France.; Tessoulin B; Department of Hematology, CHU de Nantes, Université de Nantes, CRCI²NA, Nantes, France. Electronic address: Benoit.TESSOULIN@chu-nantes.fr.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
BJS Open
Boyd, L N C, Ali, M, Comandatore, A, Brandi, G, Tavolari, S, Gaeta, R, Meijer, L L, le Large, T Y S, Riefolo, M, Vasuri, F, Morelli, L, van Laarhoven, H W M, Giovannetti, E, Kazemier, G & Garajová, I 2024, 'Prognostic value of microRNA-21 in intra-and extrahepatic cholangiocarcinoma after radical resection : cohort study', BJS open, vol. 8, no. 2, zrae031. https://doi.org/10.1093/bjsopen/zrae031
Academic Journal
Oncologist
Le Large, T Y S, Meijer, L L, Paleckyte, R, Boyd, L N C, Kok, B, Wurdinger, T, Schelfhorst, T, Piersma, S R, Pham, T V, van Grieken, N C T, Zonderhuis, B M, Daams, F, van Laarhoven, H W M, Bijlsma, M F, Jimenez, C R, Giovannetti, E & Kazemier, G 2020, 'Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma A Proteome Approach', The Oncologist, vol. 25, no. 4, pp. e634-e643. https://doi.org/10.1634/theoncologist.2019-0680
Academic Journal
Meijer, L L, Garajová, I, Caparello, C, Le Large, T Y S, Frampton, A E, Vasile, E, Funel, N, Kazemier, G & Giovannetti, E 2020, 'Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma', Annals of Surgery, vol. 271, no. 6, pp. 1137-1147. https://doi.org/10.1097/SLA.0000000000003084
Academic Journal
Ann Surg Oncol
Meijer, L L, Alberga, A J, de Bakker, J K, van der Vliet, H J, Le Large, T Y S, van Grieken, N C T, de Vries, R, Daams, F, Zonderhuis, B M & Kazemier, G 2018, 'Outcomes and Treatment Options for Duodenal Adenocarcinoma : A Systematic Review and Meta-Analysis', Annals of Surgical Oncology, vol. 25, no. 9, pp. 2681-2692. https://doi.org/10.1245/s10434-018-6567-6
Academic Journal
JAMA Netw Open
Boyd, L N C, Ali, M, Comandatore, A, Garajova, I, Kam, L, Puik, J R, Fraga Rodrigues, S M, Meijer, L L, le Large, T Y S, Besselink, M G, Morelli, L, Frampton, A, van Laarhoven, H W M, Giovannetti, E & Kazemier, G 2023, 'Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers', JAMA network open, vol. 6, no. 8, pp. e2331197. https://doi.org/10.1001/jamanetworkopen.2023.31197
Academic Journal
Beekhof, R, van Alphen, C, Henneman, A A, Knol, J C, Pham, T V, Rolfs, F, Labots, M, Henneberry, E, le Large, T Y S, de Haas, R R, Piersma, S R, Vurchio, V, Bertotti, A, Trusolino, L, Verheul, H M W & Jimenez, C R 2019, 'Correction to: INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases (Molecular Systems Biology, (2019), 15, 4, (e8250), 10.15252/msb.20188250)', Molecular Systems Biology, vol. 15, no. 5, e8981. https://doi.org/10.15252/msb.20198981
Academic Journal
Beekhof, R, van Alphen, C, Henneman, A A, Knol, J C, Pham, T V, Rolfs, F, Labots, M, Henneberry, E, Le Large, T Y S, de Haas, R R, Piersma, S R, Vurchio, V, Bertotti, A, Trusolino, L, Verheul, H M W & Jimenez, C R 2019, 'INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases (vol 15, e8250, 2019)', Molecular Systems Biology, vol. 15, no. 5.
Academic Journal
Hoebe, E K, Le Large, T Y S, Tarbouriech, N, Oosterhoff, D, de Gruijl, T D, Middeldorp, J M & Greijer, A E 2012, 'Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation', Viral immunology, vol. 25, no. 6, pp. 461-470. https://doi.org/10.1089/vim.2012.0034
검색 결과 제한하기
제한된 항목
[검색어] Le Large, Tessa Y. S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어